AOP Orphan Pharmaceuticals AG
16 clinical trials · Sponsor
◉ Watch AOP Orphan Pharmaceuticals AG
| Record | Firm | Date |
|---|---|---|
| Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH (NCT06350032) | AOP Orphan Pharmaceuticals AG | 2024-07-31 |
| Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients (NCT06317805) | AOP Orphan Pharmaceuticals AG | 2023-12-06 |
| A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients (NCT06514807) | AOP Orphan Pharmaceuticals AG | 2023-12-04 |
Track AOP Orphan Pharmaceuticals AG automatically
Every clearance here is in the API, with alerts when new ones post.